EUVIMEDEUVIMED entdecken
Fallbericht

TYK-ed off by rosacea: an Australian case series of rosacea associated with deucravacitinib

Zachary Warren iD, Chloe West iD, Christina Sander, Francis Yi Xing Lai iD

Clinical and Experimental Dermatology · 2025

DOI: 10.1093/ced/llaf418 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Zachary Warren und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Monash Health, Melbourne, VIC, Australia. Hauptthemen laut MEDLINE: Rosacea, Protein Kinase Inhibitors, TYK2 Kinase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deucravacitinib is a novel oral selective tyrosine kinase 2 inhibitor used to treat plaque psoriasis. The most common cutaneous adverse effects are acne and folliculitis. We present a series of seven patients with prototypical papulopustular rosacea (PPR) following commencement of deucravacitinib. Although most of our patients demonstrated improvement in psoriasis on deucravacitinib, all seven patients discontinued therapy because of the severity and impact of PPR. Rosacea can be a severe adverse effect of deucravacitinib, impacting tolerability and influencing future treatment options.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RosaceaProtein Kinase InhibitorsTYK2 KinaseHumansMaleFemaleMiddle AgedAdultAgedAustraliaPsoriasis

Substanzen

Protein Kinase InhibitorsTYK2 Kinase

Autor:innen und Institutionen

  • Department of Dermatology, Monash Health, Melbourne, VIC, Australia.
  • Vital Dermatology, Adelaide, SA, Australia.
  • Department of Dermatology, Flinders Medical Centre, Adelaide, SA, Australia.
  • Central Dermatology Clinic, Maroochydore, QLD, Australia.
  • Department of Dermatology, Skin Health Institute, Melbourne, VIC, Australia.

ORCID-Profile: Zachary Warren, Chloe West, Francis Yi Xing Lai

Zitieren

APA

Warren, Z., West, C., Sander, C., & Lai, F. Y. X. (2025). TYK-ed off by rosacea: an Australian case series of rosacea associated with deucravacitinib. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llaf418

Vancouver

Warren Z, West C, Sander C, Lai FYX. TYK-ed off by rosacea: an Australian case series of rosacea associated with deucravacitinib. Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llaf418

BibTeX
@article{Warren2025,
  author = {Warren, Zachary and West, Chloe and Sander, Christina and Lai, Francis Yi Xing},
  title = {TYK-ed off by rosacea: an Australian case series of rosacea associated with deucravacitinib},
  journal = {Clinical and Experimental Dermatology},
  year = {2025},
  doi = {10.1093/ced/llaf418}
}
Kostenlos starten →